Say Hello!
Don’t be shy.

   

R5 Pharmaceuticals

R5 Pharmaceuticals

Home > Investment> R5 Pharmaceuticals

R5 Pharmaceuticals developed and manufactured dosage forms for clinical trials. Their unique approach was essential to provide the right product on time and on budget.  As a consequence of their track record at achieving this, R5 was acquired in 2010 by Aesica Pharma generating BioCity a healthy return (44X).



X
X
X
X